Cargando…
Unveiling the Metabolic Effects of Glycomacropeptide
For many years, the main nitrogen source for patients with phenylketonuria (PKU) was phenylalanine-free amino acid supplements. Recently, casein glycomacropeptide (GMP) supplements have been prescribed due to its functional and sensorial properties. Nevertheless, many doubts still persist about the...
Autores principales: | Pena, Maria João, Costa, Raquel, Rodrigues, Ilda, Martins, Sandra, Guimarães, João Tiago, Faria, Ana, Calhau, Conceição, Rocha, Júlio César, Borges, Nuno |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8470927/ https://www.ncbi.nlm.nih.gov/pubmed/34575895 http://dx.doi.org/10.3390/ijms22189731 |
Ejemplares similares
-
The Use of Glycomacropeptide in Patients with Phenylketonuria: A Systematic Review and Meta-Analysis
por: Pena, Maria João, et al.
Publicado: (2018) -
Continuous use of glycomacropeptide in the nutritional management of patients with phenylketonuria: a clinical perspective
por: Pena, Maria João, et al.
Publicado: (2021) -
The Impact of the Use of Glycomacropeptide on Satiety and Dietary Intake in Phenylketonuria
por: Daly, Anne, et al.
Publicado: (2020) -
Trimethylamine increases intestinal fatty acid absorption: in vitro studies in a Caco-2 cell culture system
por: Rodrigues, Catarina, et al.
Publicado: (2023) -
Glycomacropeptide for Management of Insulin Resistance and Liver Metabolic Perturbations
por: Sauvé, Mathilde Foisy, et al.
Publicado: (2021)